Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.71 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.54 |
| ▸ | TYR | P14679 | 1/20 | 0.54 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.50 |
| ▸ | ERN1 | O75460 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12540995 | 0.89 | ALDH1A1 (0.55) | ALDH1A1TRIM24TYRTRIM33CYP1A2 | |
| SCHEMBL3633730 | 0.86 | ALDH1A1 (0.71) | ALDH1A1TRIM24TYRTRIM33CYP1A2 | |
| SCHEMBL27945949 | 0.86 | ALDH1A1 (0.56) | ALDH1A1TRIM24TYRTRIM33CYP1A2 | |
| SCHEMBL96291 | 0.83 | ALDH1A1 (1.00) | ALDH1A1TRIM24TYRTRIM33CYP1A2 | |
| SCHEMBL15329865 | 0.83 | ALDH1A1 (0.61) | ALDH1A1TRIM24TYRTRIM33CYP1A2 | |
| SCHEMBL5026272 | 0.83 | CYP1A2 (0.50) | ALDH1A1CYP1A2CYP1A1CYP1B1MAPT | |
| Hydrochloric Acid SCHEMBL9456784 | 0.82 | ALDH1A1 (0.96) | ALDH1A1TRIM24TYRTRIM33CYP1A2 | |
| SCHEMBL5561328 | 0.82 | ALDH1A1 (0.59) | ALDH1A1TRIM24TYRTRIM33CYP1A2 | |
| SCHEMBL15330720 | 0.82 | ALDH1A1 (0.59) | ALDH1A1TRIM24TYRTRIM33CYP1A2 | |
| SCHEMBL5566174 | 0.81 | ALDH1A1 (0.80) | ALDH1A1TRIM24TYRTRIM33CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200339544-A1 | Epidermal growth factor receptor inhibitors | JOINT STOCK COMPANY "BIOCAD" (RU) | 2020-10-29 | — | — | US | disclosed |
| EP-3693365-A1 | EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS | Joint Stock Company "Biocad" (RU) | 2020-08-12 | — | — | EP | disclosed |
| US-10647702-B2 | Aryl-substituted imidazoles | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2020-05-12 | — | — | US | disclosed |
| US-10647702-B2 | Aryl-substituted imidazoles | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2020-05-12 | — | — | US | disclosed |
| CN-108610332-B | Inducing MDM2 to self-degrade E3 ubiquitin ligase dimer ester small molecules PROTACs | 绍兴文理学院 | 2020-04-03 | — | — | CN | disclosed |
| CN-108610333-B | Inducing MDM2 to self-degrade E3 ubiquitin ligase dimer amide micromolecule PROTACs | 绍兴文理学院 | 2020-04-03 | — | — | CN | disclosed |
| US-20190345141-A1 | ARYL-SUBSTITUTED IMIDAZOLES | ST JUDE CHILDRENS RES HOSPITAL (US) | 2019-11-14 | — | — | US | disclosed |
| US-20190345141-A1 | ARYL-SUBSTITUTED IMIDAZOLES | ST JUDE CHILDRENS RES HOSPITAL (US) | 2019-11-14 | — | — | US | disclosed |
| US-20180291004-A1 | ARYL-SUBSTITUTED IMIDAZOLES | ST JUDE CHILDRENS RES HOSPITAL (US) | 2018-10-11 | — | — | US | disclosed |
| EP-2621275-B1 | ARYL-SUBSTITUTED IMIDAZOLES | ST JUDE CHILDRENS RES HOSPITAL (US) | 2018-03-28 | — | — | EP | disclosed |
| US-20160297800-A1 | ARYL-SUBSTITUTED IMIDAZOLES | ST JUDE CHILDREN'S RES HOSPITAL (US) | 2016-10-13 | — | — | US | disclosed |
| US-9266860-B2 | Aryl-substituted imidazoles | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2016-02-23 | — | — | US | disclosed |
| US-9266860-B2 | Aryl-substituted imidazoles | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2016-02-23 | — | — | US | disclosed |
| US-9266860-B2 | Aryl-substituted imidazoles | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2016-02-23 | — | — | US | disclosed |
| US-20130345237-A1 | ARYL-SUBSTITUTED IMIDAZOLES | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | 2013-12-26 | — | — | US | disclosed |
| EP-2621275-A1 | ARYL-SUBSTITUTED IMIDAZOLES | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2013-08-07 | — | — | EP | disclosed |
| WO-2012045018-A1 | ARYL-SUBSTITUTED IMIDAZOLES | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2012-04-05 | — | — | WO | disclosed |
| WO-2012045018-A1 | ARYL-SUBSTITUTED IMIDAZOLES | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2012-04-05 | — | — | WO | disclosed |
| EP-1896391-A2 | COMBRETASTATIN ANALOGS WITH TUBULIN BINDING ACTIVITY | Baylor University (US) | 2008-03-12 | — | — | EP | disclosed |
| WO-2006138427-A2 | COMBRETASTATIN ANALOGS WITH TUBULIN BINDING ACTIVITY | BAYLOR UNIVERSITY (US) | 2006-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130345237-A1 | ARYL-SUBSTITUTED IMIDAZOLES | MDM2, TP53, MDM4 | ALDH1A1 2758/4885TRIM24 22/4885TYR 1026/4885 |
| US-20180291004-A1 | ARYL-SUBSTITUTED IMIDAZOLES | MDM2, TP53, MDM4 | ALDH1A1 2758/4885TRIM24 22/4885TYR 1026/4885 |
| US-20190345141-A1 | ARYL-SUBSTITUTED IMIDAZOLES | MDM2, TP53, MDM4 | ALDH1A1 2758/4885TRIM24 22/4885TYR 1026/4885 |
| US-20200339544-A1 | Epidermal growth factor receptor inhibitors | EGFR, ERBB2, ERBB3 | ALDH1A1 3189/4885TRIM24 4447/4885TYR 429/4885 |
| US-10647702-B2 | Aryl-substituted imidazoles | MDM2, TP53, MDM4 | ALDH1A1 2758/4885TRIM24 22/4885TYR 1026/4885 |
| US-20160297800-A1 | ARYL-SUBSTITUTED IMIDAZOLES | MDM2, TP53, MDM4 | ALDH1A1 2758/4885TRIM24 22/4885TYR 1026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.